Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study - PubMed (original) (raw)

Apostolia-Maria Tsimberidou

Research Funding: EMD Serono (Inst), Baxter (Inst), Foundation Medicine (Inst), Onyx Pharmaceuticals (Inst), Bayer (Inst), Boston Biomedical (Inst), Placon Therapeutics (Inst)

David S. Hong

Stock and Other Ownership Interests: MolecularMatch, Oncorena

Honoraria: Adaptimmune, Baxter, Merrimack Pharmaceuticals, Bayer

Consulting or Advisory Role: Baxter, Bayer

Research Funding: Novartis, Genentech, Eisai, AstraZeneca, Pfizer, miRNA Therapeutics, Amgen, Daiichi Sankyo, Merck, Mirati Therapeutics, Eli Lilly

Travel, Accommodations, Expenses: Loxo, miRNA Therapeutics

Other Relationship: Oncorena

Yang Ye

No relationship to disclose

Carrie Cartwright

No relationship to disclose

Jennifer J. Wheler

No relationship to disclose

Gerald S. Falchook

Employment: Sarah Cannon Research Institute, HealthONE

Research Funding: GlaxoSmithKline, Millennium Pharmaceuticals, EMD Serono, Celgene, MedImmune, Genmab, Vegenics, Novartis, AstraZeneca, Incyte, ARMO BioSciences, Kolltan Pharmaceuticals, 3-V Biosciences, AbbVie, Aileron Therapeutics, DelMar Pharmaceuticals, eFFECTOR Therapeutics, Strategia Therapeutics, FujiFilm, Hutchison MediPharma, Regeneron, Biothera, Curegenics, Curis, Eli Lilly, Jounce Therapeutics, OncoMed, Precision Oncology, Syndax, Taiho Pharmaceutical, Tesaro

Patents, Royalties, Other Intellectual Property: Handbook of Targeted Cancer Therapy: Millennium

Travel, Accommodations, Expenses: Millennium Pharmaceuticals, Sarah Cannon Research Institute, EMD Serono, Bristol-Myers Squibb

Aung Naing

Consulting or Advisory Role: Novartis, CytomX Therapeutics

Research Funding: National Cancer Institute, EMD Serono, MedImmune, Healios, Atterocor, Amplimmune, ARMO BioSciences, Karyopharm Therapeutics, Incyte, Novartis, Regeneron, Baxter

Travel, Accommodations, Expenses: ARMO BioSciences

Siqing Fu

No relationship to disclose

Sarina Piha-Paul

Consulting or Advisory Role: Genentech

Research Funding: GlaxoSmithKline, XuanZhu, Puma Biotechnology, Novartis, Merck Sharp & Dohme, Curis, Principa Biopharma, Biomarin, Helix BioPharma, Bayer, AbbVie, Incyte, Five Prime Therapeutics, Cerulean Pharma, MedImmune, Medivation

Filip Janku

Stock and Other Ownership Interests: Trovagene

Consulting or Advisory Role: Deciphera, Trovagene, Novartis, Sequenom, Foundation Medicine, Guardant Health

Research Funding: Biocartis, Trovagene, Novartis, BioMed Valley Discoveries, Foundation Medicine, Roche, Agios, Astellas Pharma, Deciphera, Symphogen, Plexxikon, Piqur, FujiFilm

Other Relationship: Bio-Rad

Funda Meric-Bernstam

Honoraria: Dialecta

Consulting or Advisory Role: Genentech, Inflection Biosciences, Pieris Pharmaceuticals, Clearlight Diagnostics, Darwin Health

Research Funding: Novartis, AstraZeneca, Taiho Pharmaceutical, Genentech, Calithera Biosciences, Debiopharm Group, Bayer, Aileron Therapeutics, Puma Biotechnology, Verastem, CytomX Therapeutics, Jounce Therapeutics, Zymeworks, Effective Pharmaceuticals, Curis, Patrick Hwu

Stock and Other Ownership Interests: Lion Biotechnologies, Immatics

Consulting or Advisory Role: Lion Biotechnologies

Research Funding: Genentech

Patrick Hwu

Stock and Other Ownership Interests: Lion Biotechnolgies, Immatics

Consulting or Advisory Role: Lion Biotechnolgies

Research Funding: Genentech (Inst)

Bryan Kee

Stock and Other Ownership Interests: Medtronic

Merrill S. Kies

No relationship to disclose

Russell Broaddus

No relationship to disclose

John Mendelsohn

Leadership: Merrimack Pharmaceuticals

Stock and Other Ownership Interests: Merrimack Pharmaceuticals

Patents, Royalties, Other Intellectual Property: Royalty payments from University of California San Diego

Travel, Accommodations, Expenses: Merck

Kenneth R. Hess

Travel, Accommodations, Expenses: Angiochem

Razelle Kurzrock

Leadership: CureMatch

Stock and Other Ownership Interests: Actuate Therapeutics, CureMatch

Honoraria: XBiotech, Mayo Clinic Cancer Center, Kaiser Permanente, Health Advances, Wiley, Scripps Translational Research Institute, Defined Health, Roche

Consulting or Advisory Role: Sequenom, Actuate Therapeutics, XBiotech

Research Funding: EMD Serono (Inst), Genentech (Inst), Foundation Medicine (Inst), Pfizer (Inst), Guardant Health (Inst), Sequenom (Inst)

Patents, Royalties, Other Intellectual Property: No relationship to disclose

Travel, Accommodations, Expenses: EMD Serono, Gate-way Research Advisory Committee, Guardant Health, Global Source Ventures, Meyers Consulting, Genentech, Sylvester Cancer Center, CureMatch, Lynx Group, Mayo Clinic Cancer Center, Kaiser Permanente, Cedars-Sinai, MedImmune